{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:00:21Z","timestamp":1774904421321,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T00:00:00Z","timestamp":1365638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s40257-013-0017-9","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T08:21:59Z","timestamp":1365582119000},"page":"155-161","source":"Crossref","is-referenced-by-count":27,"title":["The Effect of Folate Supplementation on Methotrexate Efficacy and Toxicity in Psoriasis Patients and Folic Acid Use by Dermatologists in the USA"],"prefix":"10.1007","volume":"14","author":[{"given":"Amir","family":"Al-Dabagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan A.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,11]]},"reference":[{"issue":"6","key":"17_CR1","first-page":"929","volume":"20","author":"S Morgan","year":"1993","unstructured":"Morgan S, Alarcon GS, Krumdieck CL. Folic acid supplementation during methotrexate therapy: it makes sense. J Rheumatol. 1993;20(6):929\u201330.","journal-title":"J Rheumatol"},{"issue":"10","key":"17_CR2","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.20516","volume":"50","author":"SL Morgan","year":"2004","unstructured":"Morgan SL, Oster RA, Lee JY, et al. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis Rheum. 2004;50(10):3104\u201311.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"17_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.1780330102","volume":"33","author":"SL Morgan","year":"1990","unstructured":"Morgan SL, Baggott JE, Vaughn WH, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 1990;33(1):9\u201318.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"17_CR4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7326\/0003-4819-121-11-199412010-00002","volume":"121","author":"SL Morgan","year":"1994","unstructured":"Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial. Ann Intern Med. 1994;121(11):833\u201341.","journal-title":"Ann Intern Med"},{"issue":"3","key":"17_CR5","first-page":"441","volume":"25","author":"SL Morgan","year":"1998","unstructured":"Morgan SL, Baggott JE, Lee JY, et al. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol. 1998;25(3):441\u20136.","journal-title":"J Rheumatol"},{"issue":"4","key":"17_CR6","first-page":"219","volume":"63","author":"BL Masuria","year":"1997","unstructured":"Masuria BL, Mittal A, Gupta LK, et al. Methotrexate: side effects and the role of folic acid supplementation in psoriasis: a study. Indian J Dermatol Venereol Leprol. 1997;63(4):219\u201322.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"17_CR7","first-page":"249","volume":"21","author":"M Huemer","year":"2003","unstructured":"Huemer M, Fodinger M, Huemer C, et al. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study. Clin Exp Rheumatol. 2003;21(2):249\u201355.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"17_CR8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaad.2005.06.036","volume":"53","author":"BE Strober","year":"2005","unstructured":"Strober BE, Menon K. Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol. 2005;53(4):652\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"17_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","volume":"61","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section\u00a04. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61(3):451\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"17_CR10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","volume":"41","author":"AE Ede van","year":"2002","unstructured":"van Ede AE, Laan RF, Blom HJ, et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford). 2002;41(6):658\u201365.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"17_CR11","first-page":"2374","volume":"31","author":"N Hornung","year":"2004","unstructured":"Hornung N, Ellingsen T, Stengaard-Pedersen K, et al. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement. J Rheumatol. 2004;31(12):2374\u201381.","journal-title":"J Rheumatol"},{"issue":"4","key":"17_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00228-007-0442-x","volume":"64","author":"J Chladek","year":"2008","unstructured":"Chladek J, Simkova M, Vaneckova J, et al. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission\u2013induction period of treatment for moderate-to-severe plaque psoriasis. Eur J Clin Pharmacol. 2008;64(4):347\u201355.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"17_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.WNO.0000166061.73483.CE","volume":"25","author":"G Clare","year":"2005","unstructured":"Clare G, Colley S, Kennett R, et al. Reversible optic neuropathy associated with low-dose methotrexate therapy. J Neuroophthalmol. 2005;25(2):109\u201312.","journal-title":"J Neuroophthalmol"},{"issue":"26","key":"17_CR14","first-page":"991","volume":"46","author":"C Len","year":"1999","unstructured":"Len C, Hilario MO, Kawakami E, et al. Gastroduodenal lesions in children with juvenile rheumatoid arthritis. Hepatogastroenterology. 1999;46(26):991\u20136.","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"17_CR15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2133.2008.08876.x","volume":"160","author":"S Prey","year":"2009","unstructured":"Prey S, Paul C. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Br J Dermatol. 2009;160(3):622\u20138.","journal-title":"Br J Dermatol"},{"issue":"4","key":"17_CR16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(08)81746-X","volume":"31","author":"C Guzzo","year":"1994","unstructured":"Guzzo C. Folic acid supplementation with methotrexate therapy: what benefit if any? J Am Acad Dermatol. 1994;31(4):689.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"17_CR17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0889-857X(05)70369-0","volume":"23","author":"JB Shiroky","year":"1997","unstructured":"Shiroky JB. The use of folates concomitantly with low-dose pulse methotrexate. Rheum Dis Clin North Am. 1997;23(4):969\u201380.","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"17_CR18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/09546630701247930","volume":"18","author":"P Gisondi","year":"2007","unstructured":"Gisondi P, Fantuzzi F, Malerba M, et al. Folic acid in general medicine and dermatology. J Dermatolog Treat. 2007;18(3):138\u201346.","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"17_CR19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2006.01.072","volume":"55","author":"R Hughes","year":"2006","unstructured":"Hughes R, Harries M, Chalmers RJ, et al. Folic acid supplementation and methotrexate therapy for psoriasis. J Am Acad Dermatol. 2006;55(2):366\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"17_CR20","first-page":"2325","volume":"30","author":"M Hoekstra","year":"2003","unstructured":"Hoekstra M, van de Laar MA, Bernelot Moens HJ, et al. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis. J Rheumatol. 2003;30(11):2325\u20139.","journal-title":"J Rheumatol"},{"issue":"5","key":"17_CR21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.62.5.423","volume":"62","author":"M Hoekstra","year":"2003","unstructured":"Hoekstra M, van Ede AE, Haagsma CJ, et al. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(5):423\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"17_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00296-004-0537-y","volume":"25","author":"T Niehues","year":"2005","unstructured":"Niehues T, Horneff G, Michels H, et al. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria. Rheumatol Int. 2005;25(3):169\u201378.","journal-title":"Rheumatol Int"},{"issue":"11","key":"17_CR23","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/1529-0131(200011)43:11<2615::AID-ANR38>3.0.CO;2-A","volume":"43","author":"V Strand","year":"2000","unstructured":"Strand V, Morgan SL, Baggott JE, et al. Folic acid supplementation and methotrexate efficacy: comment on articles by Schiff, Emery et al, and others. Arthritis Rheum. 2000;43(11):2615\u20136.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"17_CR24","first-page":"2110","volume":"27","author":"F Bressolle","year":"2000","unstructured":"Bressolle F, Kinowski JM, Morel J, et al. Folic acid alters methotrexate availability in patients with rheumatoid arthritis. J Rheumatol. 2000;27(9):2110\u20134.","journal-title":"J Rheumatol"},{"issue":"7","key":"17_CR25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00005650-199707000-00001","volume":"35","author":"P Franks","year":"1997","unstructured":"Franks P, Clancy CM, Nutting PA. Defining primary care: empirical analysis of the National Ambulatory Medical Care Survey. Med Care. 1997;35(7):655\u201368.","journal-title":"Med Care"},{"issue":"1","key":"17_CR26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1370\/afm.620","volume":"5","author":"HJ Binns","year":"2007","unstructured":"Binns HJ, Lanier D, Pace WD, et al. Describing primary care encounters: the Primary Care Network Survey and the National Ambulatory Medical Care Survey. Ann Fam Med. 2007;5(1):39\u201347.","journal-title":"Ann Fam Med"},{"issue":"4","key":"17_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2230.2000.00638.x","volume":"25","author":"B Kirby","year":"2000","unstructured":"Kirby B, Lyon CC, Griffiths CE, et al. The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom. Clin Exp Dermatol. 2000;25(4):265\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"17_CR28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0190-9622(93)70069-6","volume":"28","author":"P Duhra","year":"1993","unstructured":"Duhra P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis. J Am Acad Dermatol. 1993;28(3):466\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"17_CR29","doi-asserted-by":"crossref","unstructured":"Griffith SM, Fisher J, Clarke S, et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5\u00a0mg daily need to continue folic acid supplements long term? Rheumatology (Oxford). 2000;39(10):1102\u20139.","DOI":"10.1093\/rheumatology\/39.10.1102"},{"issue":"6","key":"17_CR30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1365-2133.2006.07289.x","volume":"154","author":"A Salim","year":"2006","unstructured":"Salim A, Tan E, Ilchyshyn A, et al. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Br J Dermatol. 2006;154(6):1169\u201374.","journal-title":"Br J Dermatol"},{"issue":"1","key":"17_CR31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/archderm.1969.01610190092018","volume":"99","author":"HH Roenigk Jr","year":"1969","unstructured":"Roenigk HH Jr, Fowler-Bergfeld W, Curtis GH. Methotrexate for psoriasis in weekly oral doses. Arch Dermatol. 1969;99(1):86\u201393.","journal-title":"Arch Dermatol"},{"issue":"1","key":"17_CR32","first-page":"45","volume":"56","author":"FA Ive","year":"1970","unstructured":"Ive FA, De Saram CF. Methotrexate and the citrovorum factor in the treatment of psoriasis. Trans St Johns Hosp Dermatol Soc. 1970;56(1):45\u20137.","journal-title":"Trans St Johns Hosp Dermatol Soc"},{"issue":"6","key":"17_CR33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2340\/0001555572438440","volume":"72","author":"RJ Hills","year":"1992","unstructured":"Hills RJ, Ive FA. Folinic acid rescue used routinely in psoriatic patients with known methotrexate \u201csensitivity\u201d. Acta Derm Venereol. 1992;72(6):438\u201340.","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"17_CR34","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/sj.jid.5700808","volume":"127","author":"E Campalani","year":"2007","unstructured":"Campalani E, Arenas M, Marinaki AM, et al. Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis. J Invest Dermatol. 2007;127(8):1860\u20137.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"17_CR35","first-page":"459","volume":"13","author":"BF Leeb","year":"1995","unstructured":"Leeb BF, Witzmann G, Ogris E, et al. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol. 1995;13(4):459\u201363.","journal-title":"Clin Exp Rheumatol"},{"issue":"3 Suppl.","key":"17_CR36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","volume":"20","author":"RP Harris","year":"2001","unstructured":"Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 Suppl.):21\u201335.","journal-title":"Am J Prev Med"},{"issue":"1","key":"17_CR37","first-page":"36","volume":"25","author":"Z Ortiz","year":"1998","unstructured":"Ortiz Z, Shea B, Suarez-Almazor ME, et al. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: a metaanalysis of randomized controlled trials. J Rheumatol. 1998;25(1):36\u201343.","journal-title":"J Rheumatol"},{"issue":"6","key":"17_CR38","first-page":"1017","volume":"27","author":"K Visser","year":"2009","unstructured":"Visser K, van der Heijde DM. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol. 2009;27(6):1017\u201325.","journal-title":"Clin Exp Rheumatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-013-0017-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0017-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T17:17:15Z","timestamp":1715188635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-013-0017-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,11]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s40257-013-0017-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,11]]}}}